What is Ophthalmology Accounting?

Ophthalmology practice accounting is the financial management discipline for eye care practices — separating medical, surgical, optical, and cosmetic revenue streams, tracking ASC cost allocations, and reconciling implant costs per case — typically used by ophthalmologist-owners with $1M–$5M per provider who need margin clarity across a complex multi-revenue model.

Ophthalmology Accounting

An $8M practice where nobody can explain where the money goes.

Practice, ASC, and optical shop. Ophthalmology finances are tangled by default. We untangle them into clear, separate P&Ls.

Take the Free Financial Assessment →

A 4-minute test your accountant hopes you skip.

Ophthalmology Practices

At a glance

InvestmentStarting at $2,000/mo
Contract1-year, billed monthly
Setup$3,000–$9,000 onboarding
IncludesPractice + ASC P&Ls, optical tracking, surgical case economics
Guarantee45-day money back

Industry Context

How Ophthalmology Practices Actually Run Their Books

Ophthalmology practices operate as multiple businesses under one roof: clinical ophthalmology (office visits, examinations, injections), surgical operations (cataract, retina, oculoplastic), optical shop retail (frames, lenses, contacts), and often an ambulatory surgery center (ASC) that may be partially owned by the ophthalmologists. Each of these has different economics, different accounting treatment, and different tax implications. Most generic accounting setups treat the combined entity as one business and miss nearly every lever that actually drives profitability.

Ophthalmologist-owners need true segment financials. The clinical practice runs on professional fee collections with typical margins of 25 to 35 percent. The optical shop runs on product margins of 60 to 70 percent on frames and contacts with significantly different cost structure. An ASC typically runs at 30 to 50 percent EBITDA margin but requires separate financial statements, separate Medicare cost reporting, and often separate ownership structure with ophthalmologist investor-partners. Without clean segment reporting, owners cannot make informed decisions about capital allocation across these businesses.

Is This Right for You?

This service is for ophthalmology practice owners who recognize these problems:

Your ASC generates significant revenue but the shared cost allocation between your practice and the surgery center is a mess
Optical shop inventory is $200K+ and you have no real-time margin tracking on frames and lenses
Cataract surgery revenue is huge but you cannot isolate the true margin per case when you factor in implant costs and facility fees
Your Medicare population is 40% of patients and the billing complexity creates accounting headaches every month
Equipment costs $500K+ and you are not sure your depreciation schedules are optimized for tax purposes

Need strategic financial leadership? Our Fractional CFO service for ophthalmology practices may be a better fit.

What We Often Find

Common Accounting Mistakes in Ophthalmology Practices

These are the patterns we see most often when we open the books of a new ophthalmology client.

01

Lumping optical shop revenue with clinical revenue

Frames, lenses, and contacts are retail product revenue with very different gross margins and different staffing economics than clinical visits. Mixing them creates a blended margin that tells owners nothing about either business.

02

Not separating ASC revenue from practice revenue

When the ASC is owned by the practice or by a related entity, revenue flows need to be tracked separately. Most practices do this poorly, creating tax and regulatory risk in addition to obscuring ASC profitability.

03

Treating premium IOL upcharges as standard revenue

The non-covered portion of premium IOLs (multifocal, toric, EDOF) is cash collected directly from the patient and flows outside Medicare reimbursement. It should be tracked separately because it has different tax treatment and different collection dynamics.

04

Booking anti-VEGF drug revenue gross without tracking acquisition cost

Eylea, Lucentis, and Avastin flow through buy-and-bill at high dollar amounts with variable margins per drug and per payer. Tracking these as a single drug line obscures per-drug contribution margin and drug mix optimization opportunities.

05

Not amortizing capital equipment against actual case volume

A $600K femtosecond laser depreciated on a straight-line basis ignores actual case volume. True cost-per-case analysis requires allocating equipment cost against the cases where it was used.

The Numbers That Matter

Key Accounting Metrics for Ophthalmology Practices

Revenue by Segment

Clinical, surgical, optical, and ASC revenue as separate line items on segment reporting.

Premium IOL Conversion Rate

Healthy range: 25 to 40 percent in top-quartile practices

Premium lens implants divided by total cataract surgeries.

Anti-VEGF Revenue per Injection

Net revenue after drug cost per injection, by drug type.

Optical Capture Rate

Healthy range: 50 percent or higher

Percentage of refractive exam patients who purchase frames or contacts in-house.

Surgical Case Volume per Surgeon

Surgical cases per surgeon per month, by case type.

Practice Overhead Ratio

Healthy range: 55 to 65 percent

Practice operating expenses divided by practice collections (excluding ASC).

Software & Vendors

EHR, PM, and Vendor Reality for Ophthalmology Practices

Ophthalmology practices commonly run on EMA/Modernizing Medicine, Nextech, NextGen, Epic, or RevolutionEHR. Modernizing Medicine and Nextech are the most common independent platforms; Epic appears in hospital-affiliated practices; RevolutionEHR is popular in optical-focused practices. With three separate revenue sources (clinical, ASC, and optical) running on different data systems, reconciliation is harder here than in most specialties.

Drug and supply vendors heavily affect economics. Anti-VEGF manufacturers (Regeneron for Eylea, Genentech for Lucentis and Avastin, Novartis for Beovu) have varying economics that affect retina practice margins. IOL manufacturers (Alcon, Johnson & Johnson Vision, Bausch + Lomb) have preferred programs and volume discounts. Equipment vendors (Zeiss, Alcon, Topcon, Heidelberg, Lumenis) often have multi-year service contracts and consumable costs that need to be tracked separately from the capital purchase.

What's Included

How We Work With Ophthalmology Practices

Ophthalmology-specific accounting that goes beyond reconciliation.

01

ASC Financial Integration

  • Practice-ASC cost allocation and revenue sharing
  • Facility fee and professional fee separation
  • Shared resource cost tracking (staff, equipment, supplies)
  • ASC profitability analysis per procedure type
02

Optical Shop Economics

  • Frame and lens inventory management and margin tracking
  • Per-transaction profitability analysis
  • Lab cost comparison (in-house vs outsourced)
  • Insurance vs self-pay optical sales tracking
03

Surgical Case Economics

  • Per-case cost analysis (implants, supplies, staff time)
  • Premium IOL upgrade margin tracking
  • LASIK/PRK revenue and marketing cost allocation
04

Provider & Department P&Ls

  • Revenue by provider (surgeon vs optometrist vs technician)
  • Department-level P&Ls (medical, surgical, optical)
  • Medicare vs commercial profitability comparison

Results

What Ophthalmology Practices Experience

MetricTypical Outcome
ASC reallocationCorrecting shared-cost allocation added several hundred thousand dollars to reported practice profit
Premium IOL marginMargin roughly doubled through pricing and implant cost negotiation, adding six figures annually
Optical shop improvementMargin moved into the high 20s through vendor consolidation, adding roughly $90K annually

Illustrative Scenario

What This Looks Like In Practice

Illustrative, not a client testimonial. Illustrative scenario based on patterns we see in ophthalmology engagements. Not an endorsement of Sorso by any named client. Numbers shown as representative ranges.

A multi-surgeon ophthalmology practice with ASC ownership, an optical shop, and employed optometrists, combined revenue in the $8M–$10M range. Owner-surgeon take-home was below expectations. Nobody could clearly explain the financial relationship between the practice, the ASC, and the optical shop.

What we typically find:

  • ASC cost allocation subsidizing practice overhead by several hundred thousand dollars a year, so the practice looked profitable only because the ASC was absorbing shared costs disproportionately
  • Premium IOL upgrades generating meaningful patient revenue but at a sub-25% margin, driven by untracked implant costs and under-priced upgrade fees
  • The optical shop running at a low-double-digit margin versus a more typical 25–35% range, with frame purchasing fragmented across multiple vendors
  • Anti-VEGF drug waste billing (JW modifier) not being submitted, leaving mid-five figures in unbilled drug waste per year

Representative results

Correcting shared-cost allocation added several hundred thousand dollars to reported practice profit

ASC reallocation

Margin roughly doubled through pricing and implant cost negotiation, adding six figures annually

Premium IOL margin

Margin moved into the high 20s through vendor consolidation, adding roughly $90K annually

Optical shop improvement

The takeaway

The pattern we see in multi-entity ophthalmology: without clean separation between practice, ASC, and optical, shared costs quietly migrate to whichever entity the GL defaults to. One entity ends up looking healthy while another absorbs the difference.

Common Questions About Accounting for Ophthalmology Practices

Don't pay for reports. Pay for progress.

Take the 4-minute financial assessment—and find out if your books are helping or hurting your ophthalmology practice.

Take the Free Financial Assessment →

The test your accountant hopes you skip.

By state

Ophthalmology Practices accounting and CFO support, by state

State-level tax, payer, and regulatory context shapes what “good” looks like for ophthalmology practices practices. The pages below walk through each state's specifics.